We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 38,411 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/1/2018 17:17 | That's all well and good, and I agree but we've been hearing the same lines for two years! There'll come a point when the market will give up on OPTI and our price will crash! Now is the time to deliver those big deals! | f3rdinand | |
23/1/2018 17:12 | The bottom line is SoH is not your typical AIM CEO/Charlatan, he's doing things the right way, brick by brick. His hard negotiating stance and unwillingness to provide finger in the air forecasts will ultimately reap huge rewards for shareholders over the coming months and years, for now we have to put up with the frustration of a sluggish SP, but if you believe, as I do, all our stars are aligning then take the opportunity to top up (if you can afford it), because once SoH lets this genie out of the bottle then these no going back - we're going to see a rapid re-rate to 'fair value', not one built on AIM sand but backed by rock solid fundamentals. | trotterstrading | |
23/1/2018 17:02 | Bit of wishful thinking from Proactive with a typo having the share price at 635p ;-)) | aspex | |
23/1/2018 16:59 | You are right ferdy. Unfortunately the people i speak with seem to be blaming soh for tws failed targets. I wonder how many are still invested on the back of tw compared to how many are invested? IMO he needs to shut the f up with his price targets. Not everyone needs their hand holding. | slartybartfaster | |
23/1/2018 16:44 | Fine if people leave. Read what looks like is going on in the background ... There is a seller around but I think is great chance to build a substantial holding. One day all the hard work will start to feed through .. | meganxmas | |
23/1/2018 16:41 | But surely if the sheep didn't arrive in the first place then we'd still be sat at the same share price as we are now? | f3rdinand | |
23/1/2018 16:39 | Tw has gone into politician mode, or it deflection mode? He is blaming the useless fincap for opti's share price woes. The prat needs to take a good long hard look at himself for his over egging price prediction for the past 2 years. It is his fault we have drip sells because his sheep are leaving opti. | pglancy | |
23/1/2018 15:47 | IMHO TATA/SlimBiome/LPGOS are going to be a key players in India and Asia. India in particular is one of the fastest growing economies, if not the fastest. Some of the major brands are USA fast food outlets, and with a middle class population significantly greater than the whole population of the USA, the market for OPTI related products, LPGOS and SlimBiome IS huge. And with home based production, OPTI are in tariff free....something of a hurdle, by all accounts. | elrico | |
23/1/2018 15:30 | Pity there was no mention of Opti operating in the global market for natural sweeteners Though lets hope we're negotiating with all on that list :) | judijudi | |
23/1/2018 15:08 | At the end...Some of the noteworthy companies operating in the global market for natural sweeteners are Tate & Lyle PLC, Niutang Chemical Ltd., MacAndrews & Forbes Incorporated, Cargill, Incorporated, DuPont, Ajinomoto Co., Inc., Archer Daniels Midland Company, Symrise AG, Nestlé S.A., Wilmar International Limited, American Sugar Refining, Inc., Associated British Foods PLC, Ingredion Incorporated, and Roquette Frères. | parob | |
23/1/2018 14:59 | Don’t normally post, but I am a holder and just spotted this on the TATE BB. Interesting list of companies quoted at the end of the article. GLA. hxxps://www.lanews.o | yorkiemike | |
23/1/2018 14:54 | A tad bit better buying this PM | judijudi | |
23/1/2018 14:28 | The small-cap broker finnCap, reacting to the research, told investors: "This positive taste study further demonstrates the potential for SweetBiotix to replace traditional sugars and artificial sweeteners as a bulk sugar replacement that contains no calories and improves microbiome diversity." [...] | scotty1 | |
23/1/2018 14:24 | Not one comment about why a seriously heavy hitter in Neil Davidson joined Opti? | shrewdmole | |
23/1/2018 14:22 | And not small buys... I'm not getting involved in the buyer or seller debate. Like I've said before there is far more going on here than we pi's know. Just the people soh is meeting with and speaking to about the deals will speak to family and friends etc there's potentially a calorie free sugar, a hypertension reducing natural alternative to statins etc etc. I trust soh so slowly with solid foundations suits me - especially as he has more skin in the game than any of us! S | shrewdmole | |
23/1/2018 14:15 | All express readers I hear! | rafboy | |
23/1/2018 14:14 | I want serious investors in OPTI not Express readers ;) Suddenly a flurry of buys.... | f3rdinand | |
23/1/2018 13:56 | Prefer the Express :-) | zebbo | |
23/1/2018 13:40 | I'll believe it when I see it plastered over the front page of the Times and Guardian! | f3rdinand | |
23/1/2018 13:31 | F3rd - as I said this morning SOH has said this is in hand. | primal123 | |
23/1/2018 13:29 | I think I'll spend the afternoon e-mailing national newspapers, seems like SOH can't be bothered to! | f3rdinand | |
23/1/2018 13:29 | It gave the the ability to add 3k. It will not matter if some cannot read an r.n.s statement and a few are selling. A replacement for some sugars WILL be reflected in the share price... | bobdown2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions